Binding Database

The following articles (labelled with PubMed ID or TBD) are for your review

PMID

Data

Article Title

Organization

Discovery of novel and potent leukotriene B4 receptor antagonists. Part 1.

Roche Research Center

Discovery of Irbesartan Derivatives as BLT2 Agonists by Virtual Screening.

Fraunhofer Institute For Translational Medicine and Phamacology Itmp

First Structure-Activity Relationship Study of Potent BLT2 Agonists as Potential Wound-Healing Promoters.

Fraunhofer Ime

Elucidation of Mechanism for Ligand Efficacy at Leukotriene B

Incerebro

Antileukotrienic N-arylethyl-2-arylacetamides in the treatment of ulcerative colitis.

Zentiva Vufb

Synthesis and structure-activity relationships of new 1, 3-disubstituted cyclohexanes as structurally rigid leukotriene B(4) receptor antagonists.

Cnrs 5074

Prolyl hydroxylase inhibitors and methods of use

Akebia Therapeutics

Methods of use of cyclopamine analogs

Infinity Pharmaceuticals

Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics.

University of Zurich

Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.

Universitat De Barcelona

Design, synthesis, and biological evaluation of potent c-Met inhibitors.

Amgen